Vita 34 International AG Enters Cooperation for Expanding Umbilical Cord Blood Banking
Vita 34 International AG / Alliance/Product Launch
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Leipzig, November 15, 2007 - VITA 34 International AG (ISIN DE000A0BL849),
the parent company of the leading umbilical cord blood bank in the
German-speaking countries, VITA 34, is expanding its offering in the field
of the storage of stem cells from umbilical cord blood. The stem cells
stored at VITA 34 as of January 1, 2008 can additionally be made available
to a public donation registry. Thus, VITA 34 is making it possible for the
first time to combine private storage with public stem cell donations.
The specific tissue characteristics of the stem cell preparations stored at
VITA 34 can be passed on to and stored by the charitable database of NKR –
Initiative Leben spenden Deutschland. The stem cells will remain the
property of the parents, however, in case of need they can be made
available to patients worldwide with the parents’ permission. In this case
the parents will reimbursed for the costs of storage. An individual
decision, therefore, can be made as to whether the stem cells are to be
donated or continue to be available to their own child.
The public donation of umbilical cord blood for the first time throughout
Germany is made possible by the cooperation of VITA 34 with 900 birthing
clinics. VITA 34 is responding to the requests of parents and professional
organizations for a combination of own provision and umbilical cord blood
donation with this product model.
VITA 34 is then only private umbilical cord blood bank in Germany with a
pharmaceutical permit from the Paul Ehrlich Institute for the storage of
allogenic umbilical cord blood donations. Consequently, VITA 343 has all of
the official permission for storage and releasing both allogenic and
autologous blood stem cell preparations.
About VITA 34:
VITA 34 is the leading umbilical cord blood bank in the German-speaking
countries and was founded by physicians in Leipzig in 1997. To date more
than 44,000 parents have decided to have their childrens’ umbilical cord
blood placed in long-term storage with VITA 34.
About NKR:
NKR – Initiative Leben spenden Deutschland was founded in Hannover in 1996.
Today, NKR - Initiative Leben spenden Deutschland works throughout the
Federal Republic of Germany and is the third largest registry of its type
in Germany. The NKR – Initiative Leben spenden Deutschland data are
registered with the Central Bone Marrow Donor Registry Germany in Ulm
(ZKRD) and are, therefore, internationally accessible.
Press/Investor Relations:
Axel Mühlhaus
Dr. Sönke Knop
edicto GmbH
Zeisselstraße 19
D-60318 Frankfurt
Tel.:+49 (069) 90550550
Fax:+49 (069) 90550577
eMail: vita34@edicto.de
15.11.2007 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: Vita 34 International AG
Deutscher Platz 5a
04103 Leipzig
Deutschland
Phone: +49(0341)48792-40
Fax: +49(0341)48792-39
E-mail: info@vita34.de
Internet: www.vita34.de
ISIN: DE000A0BL849
WKN: A0BL84
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
